BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 38213140)

  • 1. Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer.
    Marzhoseyni Z; Shaghaghi Z; Alvandi M; Shirvani M
    Curr Cancer Drug Targets; 2024; 24(6):612-628. PubMed ID: 38213140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
    Smet A; Kupcinskas J; Link A; Hold GL; Bornschein J
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):857-874. PubMed ID: 34506954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Gut Microbiota and Gastrointestinal Cancer.
    Meng C; Bai C; Brown TD; Hood LE; Tian Q
    Genomics Proteomics Bioinformatics; 2018 Feb; 16(1):33-49. PubMed ID: 29474889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
    Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
    Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota can be a potential regulator and treatment target of bone metastasis.
    Contino KF; Yadav H; Shiozawa Y
    Biochem Pharmacol; 2022 Mar; 197():114916. PubMed ID: 35041811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy.
    Jaye K; Chang D; Li CG; Bhuyan DJ
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the gut microbiome in gastrointestinal cancers.
    Mishra Y; Ranjan A; Mishra V; Chattaraj A; Aljabali AAA; El-Tanani M; Hromić-Jahjefendić A; Uversky VN; Tambuwala MM
    Cell Signal; 2024 Mar; 115():111013. PubMed ID: 38113978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of gut microbiota in tumorigenesis and treatment.
    Xu JY; Liu MT; Tao T; Zhu X; Fei FQ
    Biomed Pharmacother; 2021 Jun; 138():111444. PubMed ID: 33662679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
    Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
    Front Immunol; 2021; 12():635704. PubMed ID: 34054805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.
    Anto L; Blesso CN
    J Nutr Biochem; 2022 Jul; 105():108991. PubMed ID: 35331903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease.
    Pilla R; Suchodolski JS
    Front Vet Sci; 2019; 6():498. PubMed ID: 31993446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota and its interactions with cardiovascular disease.
    Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L
    Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Implication of the Gut Microbiome in Heart Failure.
    Lupu VV; Adam Raileanu A; Mihai CM; Morariu ID; Lupu A; Starcea IM; Frasinariu OE; Mocanu A; Dragan F; Fotea S
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Fecal Microbiome and Correlations of the Metabolome with Plasma Metabolites in Dairy Cows with Left Displaced Abomasum.
    Luo Z; Yong K; Luo Q; Du Z; Ma L; Huang Y; Zhou T; Yao X; Shen L; Yu S; Deng J; Ren Z; Zhang Y; Yan Z; Zuo Z; Cao S
    Microbiol Spectr; 2022 Dec; 10(6):e0197222. PubMed ID: 36222683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.
    Tözün N; Vardareli E
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S191-S196. PubMed ID: 27741173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
    Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
    Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.